Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro‐oesophageal reflux disease and peptic ulcer disease

This publication has 39 references indexed in Scilit:

• Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results
  Alimentary Pharmacology & Therapeutics, 2003
• Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2 -receptor antagonists
  Alimentary Pharmacology & Therapeutics, 1999
• Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer—a European multicentre study
  Alimentary Pharmacology & Therapeutics, 1998
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996
• Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group
  JAMA, 1995
• Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration—a multicentre study
  Alimentary Pharmacology & Therapeutics, 1995
• Pantoprazole versus omeprazole in the treatment of acute gastric ulcers
  Alimentary Pharmacology & Therapeutics, 1995
• Lansoprazole versus Omeprazole in Active Duodenal Ulcer a Double-Blind, Randomized, Comparative Study
  Scandinavian Journal of Gastroenterology, 1995
• Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group
  Published by American Medical Association (AMA) ,1994
• Lansoprazole versus Omeprazole in Short-Term Treatment of Reflux Oesophagitis Results of a Scandinavian Multicentre Trial
  Scandinavian Journal of Gastroenterology, 1993